OWC Pharmaceutical Research Corp (OWCP)

[stockfan100]

Thank you for clarification, Chugger. You are absolutely right about Sheba. Here is the proof that Sheba and OWCP are working together on several clinicals. Enjoy!

High Quality Clinical Trials
OWC Pharmaceuticals’ clinical studies are being conducted at the Sheba Academic Medical Center in Tel Hashomer, Israel, in full compliance with Helsinki Committee/IRB conventions. Sheba is one of the leading medical centers in the Middle East, and one of only two facilities in Israel with the U.S. Department of Health and Human Services’ federal-wide assurance designation, which provides it with U.S. federal research grants involving human clinical trials.

https://friendsofsheba.org/owc-looks-to-bring-pharma-grade-cannabis-therapeutics-to-market/

About Friends of Sheba
Our Mission
Friends of Sheba Medical Center (FSMC) is a nonprofit organization based in Los Angeles, California. Sheba Medical Center at Tel HaShomer is the largest hospital in Israel and the entire Middle East. FSMC is dedicated to raising awareness and philanthropic support for Sheba Medical Center’s compassionate clinical care, cutting edge research and comprehensive educational training.
https://friendsofsheba.org/about-fsmc/

The Cannabis craze is on the rise, and with good reason... Scientist already know the major benefits Cannabis can bring to the medicinal table, and it seems that Israel is considered one of the best places in the world to research just how much of an impact it can make.
Check out how the OWCP signed three research collaboration and license agreements with Sheba Academic Medical Center in Tel Hashomer, and what that means for the future of alternative medicine: http://bit.ly/2jw00pK

To date, OWCP has signed three research collaboration and license agreements with Sheba Academic Medical Center, Tel Hashomer, Israel. Sheba is a university-affiliated hospital that serves as Israel’s national medical center and the most comprehensive medical center in the Middle East. Within the framework of the agreements with Sheba, OWCP will initiate three studies at the Sheba facilities to explore the effect of three formulations, all based on active ingredients in the cannabis extracts, on multiple myeloma, psoriasis and fibromyalgia (a specific formulation to each indication).

OWCP is working towards having the Tablet approved by the Israeli Medicinal Cannabis Unit under the Ministry of Health office for use within the country’s sanctioned medical cannabis program, as well as talking with potential licensees of the technology in the United States. Longer term, management expects to establish clinical tests of the Tablet in protocols for Multiple Myeloma, Post-Traumatic Stress Disorder (PTSD), and Fibromyalgia.

https://friendsofsheba.org/owc-pharmaceutical-research-corp-on-a-bull-run/